Tylenol sales in South Korean convenience stores drastically increased by as much as 99.6 percent from April to May on rumors that it helps with the fever, headache, and muscle pain that are common COVID-19 vaccine side effects.
With more South Koreans getting vaccinated for COVID-19, Tylenol is increasingly sold out at pharmacies, prompting consumers to head out to convenience stores to buy it.
Some consumers are hoarding Tylenol in anticipation of a supply crisis just like what happened with hand sanitizers and protective masks during the early stages of the pandemic.
.7-Eleven saw a 99.6 percent increase in Tylenol sales between May 27 and 30 soon after the introduction of the reservation service for ‘no-show’ vaccines, from the same period in April.
CU reported an 89.9 percent increase in Tylenol sales between May 27 and 31 from the same period in April. It was also a 125.5 percent increase compared to the same month last year,
GS25 posted a 38.8 percent increase in May from April, which was a 41.9 percent increase compared to the same month last year.
The Ministry of Food and Drug Safety reminded citizens that there are many other kinds of acetaminophen-based pain and fever reducers, offering information on some 70 similar drugs readily available in the country.


RBA Signals Possible Interest Rate Hike in 2026 as Inflation Pressures Persist
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Japan Revises Economic Growth Forecast as Stimulus Fuels Consumption and Investment
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Global Markets Rise as Tech Stocks Lead, Yen Strengthens, and Commodities Hit Record Highs
IMF Reaches Staff-Level Agreement With Egypt, Opening Path to $3.8 Billion in Funding
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
FDA Approves Mitapivat for Anemia in Thalassemia Patients
U.S. Stocks Rally to Record Highs as AI Rebound Fuels Holiday-Shortened Session
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
UBS Warns of Short-Term Risks as Precious Metals Rally to Record Highs
BOJ Governor Signals Gradual Rate Hikes as Japan’s Inflation Nears 2% Target
China’s Power Market Revamp Fuels Global Boom in Energy Storage Batteries
Gold Price Breaks $4,500 as Safe-Haven Demand and Rate Cut Bets Fuel Rally
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 



